Thermo Fisher Scientific Inc said on Monday its Covid-19 diagnostic tests can accurately detect the new coronavirus variant Omicron
The company, one of the major providers of coronavirus tests, benefited from strong demand during the pandemic
The deal represents a purchase price of about $7.2 billion including about $2.0 billion of net debt